drug
Lemtrada
Marketedupdated 3mo agoby Genzyme Corp
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Lemtrada
- —A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
- phase1Tolerance by Engaging Antigen During Cellular Homeostasis
- phase3A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
- phase2Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
- phase2Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
- —Physical and Cognitive Performance During the Two First Years of Lemtrada Treatment
- phase2Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that